Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

346

HTML

2498

Tables (1-4)

215

Sum=3059

Feb 15, 2001 (publication date) through Nov 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Feb 15, 2001; 7(1): 28-32
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.28

Table 2 Survival time and rates of patients with PVTT

	Group A (n = 18)	Group B (n = 18)	Group C (n = 74)	Group D (n = 29)
Median survival periods (months)	2.0	5.0	12.0	16.0
Survival rates
1-year (%)	5.6	22.2	53.9^a2	79.3^a1
3-year (%)	0	5.6	26.9^a2	38.9^a1
5-year (%)	0	0	16.6^a2	26.8^a1

^a1P < 0.05, vs Group C, B and A;

^a2P < 0.05, vs Group B and C.

Citation: Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Ye SL. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol 2001; 7(1): 28-32
URL: https://www.wjgnet.com/1007-9327/full/v7/i1/28.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i1.28